Keyphrases
Stem Cell-derived
100%
Chemotherapy
100%
Acute Myeloid Leukemia Cells
100%
Cell Killing
100%
Natural Killer Cells
100%
Induced Pluripotent Stem Cells (iPSCs)
100%
Acute Myeloid Leukemia
44%
Natural Killer
33%
Leukemia Patients
22%
Cytarabine
22%
Apoptosis
11%
CD38
11%
Treatment Options
11%
High Risk
11%
Standard of Care
11%
Cell Death
11%
Adverse Effects
11%
Flow Cytometric Analysis
11%
Leukemia Cell Lines
11%
Clinical High Risk
11%
High Affinity
11%
Leukemia Therapy
11%
Antibody-dependent Cellular Cytotoxicity
11%
Promising Treatment
11%
CD16
11%
Cell Ratio
11%
Treatment Combination
11%
Interleukin-15 (IL-15)
11%
IL-15 Receptor
11%
Wider Population
11%
Ratio-dependent
11%
Disease Resistant
11%
Natural Killer Cell Therapy
11%
Venetoclax
11%
Gilteritinib
11%
Metabolic Fitness
11%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Leukemia Cell
100%
Natural Killer Cell
100%
Cell Killing
100%
Induced Pluripotent Stem Cell
100%
Cytarabine
22%
Interleukin 15
22%
Diseases
11%
Programmed Cell Death
11%
Cytokine
11%
Cell Line
11%
Cell Death
11%
Receptor
11%
Target Cell
11%
Adverse Effect
11%
Cell Therapy
11%
Antibody Dependent Cellular Cytotoxicity
11%
Acute Myeloid Leukemia Cell Line
11%
Venetoclax
11%
Gilteritinib
11%
Immunology and Microbiology